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Key points
 The aim of this study was to determine the effect of rotational axis position (RAP and thus
g-gradient) during short-arm human centrifugation (SAHC) upon cardiovascular responses,
cerebral perfusion and g-tolerance.
 In 10 male and 10 female participants, 10 min passive SAHC runs were performed with the
RAP above the head (P1), at the apex of the head (P2), or at heart level (P3), with foot-level
Gz at 1.0 g, 1.7 g and 2.4 g.
 We hypothesized that movement of the RAP from above the head (the conventional position)
towards the heart might reduce central hypovolaemia, limit cardiovascular responses, aid
cerebral perfusion, and thus promote g-tolerance.
 Moving the RAP footward towards the heart decreased the cerebral tissue saturation index,
calf circumference and heart rate responses to SAHC, thereby promoting g-tolerance.
 Our results also suggest that RAP, and thus g-gradient, warrants further investigation as it may
support use as a holistic spaceflight countermeasure.
Abstract Artificial gravity (AG) through short-arm human centrifugation (SAHC) has been
proposed as a holistic spaceflight countermeasure. Movement of the rotational axis position (RAP)
from above the head towards the heart may reduce central hypovolaemia, aid cerebral perfusion,
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and thus promote g-tolerance. This study determined the effect of RAP upon cardiovascular
responses, peripheral blood displacement (i.e. central hypovolaemia), cerebral perfusion and
g-tolerance, and their inter-relationships. Twenty (10 male) healthy participants (26.2 ± 4.0 years)
underwent nine (following a familiarization run) randomized 10 min passive SAHC runs with
RAP set above the head (P1), at the apex of the head (P2), or at heart level (P3) with foot-level Gz
at 1.0 g, 1.7 g and 2.4 g. Cerebral tissue saturation index (cTSI, cerebral perfusion surrogate), calf
circumference (CC, central hypovolaemia), heart rate (HR) and digital heart-level mean arterial
blood pressure (MAP) were continuously recorded, in addition to incidence of pre-syncopal
symptoms (PSS). CC and HR increases were attenuated from P1 to P3 (CC: 5.46 ± 0.54 mm
to 2.23±0.42 mm;HR: 50±4 bpm to 8±2 bpm, P<0.05). In addition,cTSI decrements were
also attenuated (cTSI: −2.85 ± 0.48% to −0.95 ± 0.34%, P < 0.05) and PSS incidence lower in
P3 than P1 (P < 0.05). A positive linear relationship was observed between CC and HR with
increasing +Gz, and a negative relationship between CC and cTSI, both independent of RAP.
Our data suggest that movement of RAP towards the heart (reduced g-gradient), independent
of foot-level Gz, leads to improved g-tolerance. Further investigations are required to assess the
effect of differential baroreceptor feedback (i.e. aortic–carotid g-gradient).
(Received 10 March 2020; accepted after revision 8 July 2020; first published online 27 July 2020)
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Introduction
Immediately upon standing from the supine position,
blood pressure remains unaltered at certain locations
within the arterial, venous and other fluid-filled
compartments of the body, termed hydrostatic
indifference points (HIPs, Kirsch et al. 1982). The locations
of the HIPs depends on a number of factors, including
filling volumes and sympathetic tone, yet the arterial
supine-to-upright HIP has been localized at heart (aortic
arch) level, whereas the venous supine-to-upright HIP
is several centimetres below the apex of the diaphragm,
i.e. liver level (Hinghofer-Szalkay, 2011). As a result,
receptors located at an HIP would not sense any pressure
changes upon standing; in the arterial system, this
applies to the aortic baroreceptors, which therefore convey
information on systemic blood pressure undisturbed
by the effects of postural changes. In contrast, carotid
baroreceptors are positioned so that they can serve as
the sentinels of cerebral perfusion (Mancia et al. 1984).
Thus, with standing, carotid baroreceptors experience
reduced vessel-wall stress and consequently exert positive
chronotropic and inotropic effects upon the heart.
Similarly, cardiopulmonary (‘volume’) receptors that are
above the venous HIP level sense a pressure drop with
supine-to-upright positional changes, and therefore are
also able to initiate cardiovascular responses (Hainsworth,
2014).
Exposure to microgravity induces a number of
deleterious effects on humans including muscle atrophy,
loss of bone mineral density and cardiorespiratory
deconditioning including orthostatic intolerance (OI)
(see Hargens & Richardson, 2009; Blaber et al. 2011;
Goswami et al. 2012, 2013; Goswami, 2017). In addition
to microgravity-induced unloading, there is a headward
fluid shift away from the lower limbs following the loss of
the hydrostatic pressure gradient (Thornton & Hoffler,
1977). Long-arm human centrifugation (LAHC) and
high-performance aircraft g-exposure is associated with
relatively dose-dependent effects of +Gz upon the cardio-
vascular system and g-tolerance. G-tolerance is limited
by an individual’s ability to maintain cerebral perfusion
which is impaired despite there being no significant
g-gradient (i.e. almost constant gravitational force is
experienced at the head and feet, Scott et al. 2007).
Repeated exposure to LAHC can improve orthostatic
tolerance (Scott et al. 2013), but is impractical and thus
unlikely to be employed during spaceflight (Clément &
Pavy-Le Traon, 2004).
However, recent research on Earth has shown that
periodically shifting central blood volume to the peri-
phery, through provision of artificial gravity (AG) of
+2.4 Gz via short-arm human centrifuge (SAHC) leads
to significant improvements in subsequent standing
orthostatic tolerance (Goswami et al. 2015b). SAHC is
significantly more practical but leads to a g-gradient where
a substantially greater +Gz is experienced at the feet
than the head (Clement & Pavy-Le Traon, 2004). As a
result, SAHC is associated with central hypovolaemia and
syncope (Evans et al. 2015; Goswami et al. 2015b; White
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et al. 2019), which is a potentially critical situation should
it occur in space. Whilst the AG required to ameliorate
muscle atrophy, loss of bone mineral density and cardio-
respiratory deconditioning is currently unknown, research
has been instigated in order to optimize the AG ‘dose’
(i.e. duration and magnitude of exposure in terms of OI).
However, to our knowledge no research has characterized
the effects of varying the g-gradient.
We hypothesize that the physiological responses to
SAHC-induced AG will differ between rotational axis
position (RAP) since the hydrostatic pressure rises
continually from head to foot when the rotation axis
occurs above the head outside the body, but rises in
both directions away from the rotation axis when it
occurs within the body (Fig. 1). As a result, an RAP shift
from above the head to heart level during SAHC, with a
fixed g-level at the feet, may improve g-tolerance through
attenuation of central hypovolaemia and impairment
of cerebral perfusion. Furthermore, RAP – and thus
the g-gradient – will modulate the hydrostatic gradient
between the carotid and aortic baroreceptors and thus
cardiac filling, which should in turn affect the cardio-
vascular response to SAHC at a given AG, which may
modulate g-tolerance.
Thus the aim of the study was to investigate the
effect of three standardised RAPs and the head-to-heart
and heart-to-foot hydrostatic component (g-gradient) of
blood pressure upon the cardiovascular responses, peri-
pheral blood displacement (i.e. central hypovolaemia),
cerebral perfusion and g-tolerance, in addition to the
relationship between peripheral blood displacement, and
both heart rate (HR) and cerebral perfusion with respect
to g and RAP.
Methods
Ethical approval
The study conformed to the Declaration of Helsinki,
including registration with the German Clinical Trial
Registry (DRKS), and was approved by the Ethics
Committee of the North Rhine Medical Association in
Düsseldorf, Germany (Ref: 2015381). All participants gave
written informed consent to participate in the study.
Study design and participants
Twenty (10 male) healthy normotensive, non-smoking
participants (mean ± SD age: 26.2 ± 4.0 years; height:
1.73 ± 0.08 m; and BMI: 22.9 ± 1.7 kg m−2; Table 1) took
part in the study.
Before being enrolled in the study, all participants
underwent medical screening which consisted of: clinical
chemical analysis (glucose, creatinine, urea, uric acid, liver
enzymes, total cholesterol, high density lipoprotein (HDL)
and low density lipoprotein (LDL)); haematology (blood
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Figure 1. Hydrostatic pressure as a
function of centrifuge radius and
angular velocity
A standard 1.73 m tall male participant is
represented with the feet placed at an
acceleration of 2.4 g (drawn as a function
of angular velocity and centrifuge radius).
Anthropometric positioning of eye level,
carotid and aortic baroreceptors and heart
levels are indicated for each of the three
centrifuge positions P1, P2 and P3. For a
description of pressure calculations see
Table 5.
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P01 M 24.1 1.75 65 21.2
P02 F 28.0 1.60 57 22.3
P03 F 26.4 1.71 64 21.9
P04 F 23.6 1.68 72 25.5
P05 F 21.8 1.64 70 26.0
P06 F 26.5 1.70 58 20.1
P07 F 29.4 1.61 51 19.7
P08 F 20.5 1.70 65 22.5
P09 F 26.4 1.60 60 23.4
P10 M 35.9 1.86 80 23.1
P11 M 22.5 1.73 69 23.1
P12 M 23.5 1.81 75 22.9
P13 F 24.1 1.73 65 21.7
P14 F 31.6 1.70 67 23.2
P15 M 33.2 1.85 82 24.0
P16 M 25.6 1.78 73 23.0
P17 M 29.2 1.75 75 24.5
P18 M 26.3 1.84 87 25.7
P19 M 21.7 1.75 65 21.2
P20 M 25.9 1.72 68 23.0
Mean ± SD – 26.2 ± 4.0 1.73 ± 0.08 68 ± 9 22.9 ± 1.7
drugs); resting electrocardiogram (ECG); an exercise
test to verify aerobic fitness; a standing test to assess
orthostatic tolerance; and a complete medical history.
Female participants had to test negative on a urine-based
pregnancy test before each session. Prior to testing, each
participant was familiarized with all aspects of the study,
including the methodology, personnel involved and the
SAHC (Fig. 2A).
Participants underwent nine (following a
familiarization run) passive 10 min short-arm
centrifugations on the unique :enviFuge SAHC at
the German Aerospace Centre (DLR, Cologne, Germany)
over two experimental sessions on separate days (2 months
apart) with rest phases of at least 25 min between each of
the five runs per day (Fig. 2A). Each participant was tested
on both occasions either in the morning (09:00–13:00) or
afternoon (13:00–17:00) on both occasions. Prior to each
centrifugation session participants were instructed to eat
a light breakfast or lunch 1 h before. For both sessions,
participants were asked not to consume alcohol or caffeine
in the preceding 24 h. Participants lay supine astride a
saddle to support them whilst minimising muscle pump
activation (including remaining silent and completely
still unless experiencing significant discomfort) which
was confirmed via video monitoring of the lower limbs.
Each centrifuge run was performed at one of three centres
of rotation (above the head, P1; apex of the head, P2;
and at the heart, P3) thereby generating three differing
g-gradients across the body, standardized against the
anatomical position of the heart (third intercostal space),
for each participant at each of three standardized g-levels
at the feet (+1.0 Gz, +1.7 Gz and +2.4 Gz). G-gradients
are expressed as the percentage difference of g-level at the
head in relation to g-level at the feet. At +2.4 Gz at the
feet, the g-level at the head is +0.5 at P1, 0.0 at P2 and
−0.7 Gz at P3. These give rise to differences of +1.9, +2.4
and +3.1 Gz (P1, P2 and P3, respectively) and g-gradients
of +81%, P1; +100%, P2; and +130%, P3 (Table 2; and
grey shaded area, Fig. 2B).
Each of the two testing days consisted of five
centrifuge profiles (Fig. 3A), with the runs after
familiarization randomly assigned with an online
randomizer (random.org, 2016). Each centrifuge profile
was split into five phases (Fig. 3A) with a standardized
ramp-up and −down time (120 s) irrespective of g-level
to negate the documented effect of g-onset time upon
cardiovascular responses (Whinnery & Forster, 2013).
Figure 2. Protocol overview
A, enviFuge short-arm human centrifuge (SAHC) with the unique
capability to alter rotational axis position and thus g-gradient (at
DLR, Cologne, Germany). B, three centres of rotation: P1, above the
head; P2, apex of head; and P3 at heart level and three g-levels at
the feet: G1, +1.0 Gz; G2, +1.7 Gz; and G3, +2.4 Gz. Grey shaded
area, altered g-gradient across the body at each rotational axis
position: P1, P2 and P3 (at +2.4 Gz; Table 2). [Colour figure can be
viewed at wileyonlinelibrary.com]
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Table 2. Effective g-level and g-gradient for participants at



















+1.1 +2.4 +1.4 +62
P1 +0.5 +2.4 +1.9 +81
P2 +0.0 +2.4 +2.4 +100
P3 −0.7 +2.4 +3.1 +130
P1, above head; P2, head apex; and P3, heart level. G-gradient
defined as the percentage difference between g-level at the
head and feet at +2.4 Gz.
Cerebral perfusion
Cerebral near-infrared spectroscopy of the left pre-
frontal cortex immediately below the forehead hairline
of each participant (cNIRS; PortaLite, Artinis Medical
Systems, The Netherlands) was used to determine the
absolute ratio of oxy- and deoxy-haemoglobin. Taking into
account participant frontal cranium thickness, estimated
according to age and sex, the cerebral tissue saturation
index (cTSI) was deduced (Lynnerup et al. 2005). cTSI
has been proposed as a surrogate index of global cerebral
perfusion (Weiss et al. 2005).
Central hypovolaemia
Movement of fluid to the lower extremities, and away from
the central compartment (central hypovolaemia), was
quantified using strain gauge plethysmography (SGP; EC6
Strain Gauge Plethysmograph, Hokanson Inc., Bellevue,
WA, USA) positioned around the calf midpoint (directly
between the tibiae tuberosity and medial malleolus bony
prominences) of each participant.
Systemic cardiovascular measurements
Continuous beat-by-beat HR via a standard three-lead
electrocardiogram (Biopac Systems, Goleta, CA, USA) and
mean arterial finger blood pressure (MAP) was recorded
with a Finometer (Finapres Medical Systems, Amsterdam,
The Netherlands). The Finometer finger cuff was placed
around the third finger of the right hand and fixed by a
sling at the level of the fourth intercostal space (i.e. heart
level). Finometer BP measurements were corroborated
with absolute arterial BP measurements obtained by
an automated sphygmomanometer (Intellivue MMS
X2, Philips, Best, The Netherlands) prior to starting
each profile. Stroke volume (SV) and total peripheral
resistance (TPR) was estimated from the arterial BP
waveform using the Modelflow method (Leonetti et al.
2004) via Beatscope software (TNO-TPD, Biomedical
Instrumentation, Amsterdam, The Netherlands).
Pre-syncopal symptoms
For each centrifuge run all participants were classified as
experiencing pre-syncopal symptoms (PSS+) when one
(or more) of the following was observed: (i) reduction of
HR and BP > 15 s; (ii) nausea, paleness, dizziness; and
(iii) participant requested run termination (see Goswami
et al. 2009; Cvirn et al. 2012).
Participants were regularly asked during centrifugation
whether they were experiencing any motion sickness
symptoms, and to report any unexpected symptoms such
as tunnel vision or tumbling sensations, in addition
to continuous monitoring of a live video feed by an
experienced physician.
Statistical analysis
Following a pilot study of the measures used in this paper,
in which comparable fluid shifts were induced via lower
limb venous occlusion, accepting an error probability (α)
of 0.05, power (1 - β) of 0.80 with an average effect size (d)
of 0.05, a power calculation, using G∗ Power (Erdfelder
et al. 1996) yielded a participant number of 15. However,
A
B









10 min 2 min 10 min 10 min
Continuous hemodynamics measurements
Figure 3. Protocol with example
centrifuge profile phases
A, protocol consisting of five randomized
centrifuge profiles (34 min each), with no
less than 10 min rest between them. B,
single centrifuge profile consisting of five
phases: baseline, ramp-up, centrifuge run,
ramp-down and recovery.
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given the risk of attrition in the study, an additional 25%
participants were recruited.
All continuously recorded data were inspected in 10 s
frames and artefacts removed with a Matlab (R2015a, The
Mathworks Inc.) function using the following criteria:
(i) physiologically plausible limits; and (ii) maximal
percentage of change in relation to the standard deviation
of the signal. Data were resampled at 4 Hz (piecewise cubic
spline interpolation) as long as >95% of data were valid
(<5% artefact removal rate) yielding 15 complete sets of
data for further analysis. Summary data are presented as
means ± standard deviation (SD) unless otherwise stated.
Mean 2 min changes (delta) from the mean of the final
5 min of the 10 min baseline immediately before each
corresponding centrifuge run were analysed.
Data are presented as mean 2 min changes (delta)
from the mean of the final 5 min of the 10 min baseline
immediately before each corresponding centrifuge run.
R (R Core Team, 2012) and lme4 (Bates et al. 2012)
were used to perform linear mixed effect analyses of the
relationship between each cardiovascular parameter and
the time course of each centrifuge run. Time, position
and g-level at the feet (with two- and three-way inter-
actions) were entered into the model with intercepts for
each participant as a random effect. Visual inspection of
residual plots did not reveal any obvious deviations from
homoscedasticity or residual normality. P values were
obtained by likelihood ratio tests of the full model with the
effect (time, position and g-level at the feet) in question,
against the model without that effect.
To reduce complexity of the models, secondary
analysis was performed with data both averaged for
each 2 min increment of centrifugation and compared
for differences arising due to position at that moment.
To evaluate the differences induced (e.g. P1 vs. P3),
one-way analyses of variance were conducted, followed
by post hoc tests (Tukey’s honestly significant difference)
to determine effect location (i.e. time, and thus phase,
in centrifugation). Chi-squared testing was employed
to evaluate the frequency of PSS+ classification during
runs at each position across all g-levels (+1.0, +1.7 and
+2.4 Gz).
Results
G-gradient, g-level and duration
Significant changes were observed in all measured cardio-
vascular variables except MAP where there was a strong
trend for time (i.e. centrifugation) (Table 3; P < 0.05). All
parameters were significantly affected by g-level, and all
but CO were affected by position (Table 4; P < 0.05). As
there was a significant effect of g-level on all parameters,
for clarity the figures only show P3 and P1 +2.4 Gz data
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Table 4. Delta response (±SD) of cardiovascular variables as a
function of position (P1–3) at +2.4 Gz in the final minute of
centrifugation (minute 10) (n = 15) based on P1 vs. P(n), via
Tukey’s honestly significant difference. ∗P < 0.05
Tenth minute @ +2.4 Gz
P1 P2 P3
cTSI (%) −2.85 ± 1.86 −1.88 ± 1.43∗ −0.95 ± 1.32∗
CC (mm) 5.46 ± 2.09 4.11 ± 2.44∗ 2.23 ± 1.63∗
HR (bpm) 50.0 ± 15.5 24.0 ± 11.62∗ 8.0 ± 7.75∗
SV (ml) −37.7 ± 12.0 −27.2 ± 9.30∗ −19.4 ± 6.58∗
TPR
(dyn.s.cm−5)
204 ± 290 223 ± 205 169 ± 136∗
MAP
(mmHg)
4.43 ± 18.10 4.60 ± 9.10 −3.87 ± 3.25∗
CO (l min−1) −0.64 ± 1.32 −0.59 ± 0.77 −0.69 ± 0.39
cTSI, cerebral tissue saturation index; CC, calf circumference –
strain gauge plethysmography; HR, heart rate; SV, stroke volume;
TPR, total peripheral resistance; MAP, mean arterial pressure; CO,
cardiac output.
between those of P1 and P3 across the entire
centrifuge run (ramp-up, centrifugation, ramp-down and
recovery).
Cerebral perfusion and central hypovolaemia
Delta cerebral perfusion (cTSI) reductions were
significantly attenuated from the fourth minute until the
end of the ramp-down phase between P1 and P3 at+2.4 Gz
(Fig. 4A). Conversely, delta calf circumference (CC)
increases were significantly attenuated between P1 and
P3 in the final 2 min of centrifugation, the ramp-down
phase and the first 2 min of recovery (Fig. 4B).
Attenuated cardiovascular responses
Moving RAP towards the body (P3) and away from
‘classical centrifugation’ (P1) resulted in significant
attenuation of HR (Fig. 5A) and MAP (Fig. 5B) increases,
and SV (Fig. 5C) decreases in response to centrifugation.
However, attenuation of early phase TPR increments
(observed in P1) was significant only in the second and
fourth minutes (Fig. 5B).
Delta heart rate (HR) acceleration was greatest in
the final minute of centrifugation in both P1 and P3;
albeit significantly less in the latter (HR: 50 ± 4 bpm
to 8 ± 2 bpm, P < 0.05; Fig. 5A). Delta mean arterial
pressure (MAP) remained essentially unchanged during
P3 centrifugation (Fig. 5B) in contrast to during P1
where substantial increments were observed, peaking at
the second minute before progressively reducing through
the remaining centrifugation run (Fig. 5B). Thus, MAP
was significantly (P < 0.05) higher during the entire
centrifugation phase in P1 vs. P3, and then lower in P1
(vs. P3) (7.05 ± 2.92 mmHg to −1.94 ± 0.98 mmHg)
in the first minute following ramp-down as no rebound
was evident (P1 vs. P3, MAP: −7.05 ± 2.92 mmHg to
−1.94 ± 0.98 mmHg, P < 0.05; Fig. 5B). Delta stroke
volume (SV) reductions were significantly lower in P1
from the second minute of centrifugation onwards until
the end (Fig. 5C). Delta total peripheral resistance (TPR)
increments were unaffected by position, except from the
second and fourth minutes, where it was significantly
lower in P3 (Fig. 5D).
Figure 4. Mean (±SD) delta cerebral tissue saturation index
(cTSI) and calf circumference (CC) in P1 vs. P3 at +2.4 Gz
Shading: light grey (-2 to 0 min and 10 to 12 min) centrifuge
ramp-up and ramp-down phases respectively; dark grey (0 to
10 min) centrifuge run phase at +2.4 Gz; white (12 to 22 min)
recovery phase. Continuous line: rotational axis position above head
(P1) with +2.4 Gz; dotted line: rotational axis position at heart level
(P3) with +2.4 Gz. Mean delta (from 5 min mean of respective
baseline immediately before) during the ramp-up, run, ramp-down
and recovery phases of centrifugation in P1 vs. P3 at 2.4 +Gz: A,
mean delta cerebral tissue saturation index (cTSI); and B, mean
delta calf circumference (CC). Positions were compared via Tukey’s
honesty significant difference testing (n = 15); cTSI. Position:
F8,171 = 1194; CC, position: F8,171 = 1035, ∗ P < 0.05.
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Increased g-tolerance
The proportion of participants classified as experiencing
PSS+ was significantly (P < 0.05) lower at P3 vs. P1 across
the +Gz levels (Fig. 6). The proportion in P2 also tended
to be lower than P1, albeit not significant.
Unsupported cerebral perfusion
A strong positive linear relationship was observed between
CC and HR with increasing +Gz, independent
of position (Fig. 7A). In contrast, CC vs. cTSI
demonstrated a strong negative relationship with +Gz,
independent of position (Fig. 7B).
Discussion
The purpose of the study was to investigate (for the
first time) the effect of three standardised RAPs and the
head-to-heart and heart-to-foot hydrostatic component
(g-gradient) of blood pressure upon the cardiovascular
responses, peripheral blood displacement (i.e. central
hypovolaemia), cerebral perfusion and g-tolerance, in
addition to the relationship between peripheral blood
displacement, and both HR and cerebral perfusion
with respect to g and RAP. Specifically, we sought:
(i) to determine physiological differences to positive
and negative heart-to-head g-gradients by measuring
cerebral perfusion, systemic cardiovascular responses
and the emergence of pre-syncopal symptoms indicative
of g-intolerance; and (ii) provide a better insight for
future artificial gravity research by characterizing the
third variable in human centrifugation studies (namely
rotational axis placement in addition to duration and
magnitude of exposure). The main findings were that a
reduced or negative heart-to-head g-gradient significantly
attenuated the reduction in cerebral perfusion and central
hypovolaemia, the acceleration of HR and indicators of
g-intolerance.
Figure 5. Mean (± SD) delta heart rate (HR), mean arterial pressure (MAP), stroke volume (SV) and
total peripheral resistance (TPR) in P1 vs. P3 at 2.4 +Gz
Shading: light grey (-2 to 0 min and 10 to 12 min) centrifuge ramp-up and ramp-down phases respectively;
dark grey (0 to 10 min) centrifuge run phase at +2.4 Gz; white (12 to 22 min) recovery phase. Continuous line:
rotational axis position above head (P1) with +2.4 Gz; dotted line: rotational axis position at heart level (P3) with
+2.4 Gz. Mean delta of all participants (from 5 min mean of respective baseline immediately before) during the
ramp-up, run, ramp-down and recovery phases of centrifugation in P1 vs.P3 at +2.4 Gz: A, mean delta heart
rate (HR); B, mean delta mean arterial pressure (MAP); C, mean delta stroke volume (SV); and D, total
peripheral resistance (TPR). Positions were compared via Tukey’s honesty significant difference testing (n = 15);
HR, position: F8,171 = 1194; SV, position: F8,171 = 1035; TPR, position: F8,171 = 1035. ∗ P < 0.05.
C© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Cardiovascular receptors, HIPs and gravitational fields
In P1, the fluid shifts and overall cardiovascular loading is
comparable to that of upright standing (Goswami et al.
2015a). In contrast, increasing footward g-load in P3
offers a unique situation: minimal hydrostatic signal to
the cardiopulmonary and aortic baroreceptors (since they
sit on, or very close to, the RAP) whilst the carotid
receptors experience positive g-gradient loading, albeit
relatively small (e.g. approximately about 5 mmHg in
Fig. 1) given that there is a distance of 15–20 cm to the
heart.
In fact, pressure sensitive receptor stimulation consists
of two parts: direct hydrostatic effects due to the position
within the vascular compartment (arterial, venous); and
secondary blood shifts due to acceleration gradients
throughout the entire system. Even if a baroreceptor
remains unaffected at the onset of centrifugation by being
located at the centre of rotation, the g-gradient will
redistribute blood causing local pressure changes, which
will initiate secondary reflex cardiovascular responses. The
effects of altered pressure gradients when RAP is changed
are demonstrated in Fig. 1. The diversion from changes
under normal orthostatic standing challenge to those
observed during centrifugation is presented in Table 5.
However, the positions of arterial and venous HIPs during
centrifugation, and their dependence on absolute g-force
and body positioning within the respective g-field, has yet
to be determined.
Figure 6. G-tolerance in each position across all g-levels (+1.0,
+1.7 and +2.4 Gz)
All participants were exposed to nine centrifuge profiles giving rise
to 180 separate centrifuge runs, consisting of 60 in each position:
P1, rotational axis position (RAP) above head; P2, RAP head apex; P3,
RAP heart level. Participants classified as having experienced
pre-syncopal symptoms (PSS+, white) or not experiencing PSS (PSS-,
black). Levels were compared via Chi-squared testing (n = 15); c2(1,










0 1 2 3 4 5 6




























Figure 7. Relationship between mean delta heart rate (HR)
and cerebral tissue saturation index (cTSI) vs. calf
circumference (CC) during centrifugation at all g-levels and
positions
Black line: rotational axis position above head (P1); grey line:
rotational axis position at apex of head (P2); dotted line: rotational
axis position at heart level (P3); white circle: g-level 1.0 +Gz at feet
(G1); light grey circle: g-level 1.7 +Gz at feet (G2); dark grey circle:
g-level 2.4 +Gz at feet (G3). A, mean ± SD delta heart rate (HR)
and B, mean delta cerebral tissue saturation index (cTSI) against
delta calf circumference (CC) obtained from the last minute of
each centrifuge run. Relationships between parameters were
assessed via Pearson correlation (n = 15). ∗P < 0.05.
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Table 5. Estimated hydrostatic blood pressure differences between the heart and cardiovascular points on the body based on the












rp (m) 0.49 0.59 0.70 0.92 0.97 2.22
Pheart (mmHg) −29.7 −24.8 −18.9 −4.3 0 166
P2
rp (m) 0 0.11 0.22 0.43 0.49 1.73
Pheart (mmHg) −12.7 −12.0 −10.2 −2.7 0 148
P3
rp (m) 0.49 0.38 0.27 0.05 0 1.24
Pheart (mmHg) 17.6 10.7 5.4 0.2 0 115
Standing
h (m) 1.73 1.62 1.51 1.30 1.24 0
Pheart (mmHg) −37.6 −29.2 −20.9 −4.2 0 96.0
Centrifuge: Pheart: pressure difference between body point and heart level {= ρ kBPgfoot/hfoot(r2p − r2heart), ρ: density of blood
1050 kg/m3, kBP: 0.0075 (conversion factor: Pa to mmHg), rp: distance from centre of centrifuge}.
Standing: Pheart: pressure difference between body point and heart level {= ρkBPgh, ρ: density of blood, kBP: 0.0075 (conversion
factor Pa to mmHg), h: vertical distance between the height of the heart and height from the feet (h)}.
Initial response
Delta calf circumference was unchanged by position in
the initial stages of centrifugation (up until minute eight)
whilst cTSI was significantly lower at +2.4 Gz in P1
than P3 from the fourth minute onwards. This finding
suggests that cerebral perfusion was attenuated earlier
than significant peripheral fluid shifts indicated by CC,
presumably due to a varied peripheral vascular response to
early orthostatic stimulation (Watenpaugh et al. 2004). By
the final minute of centrifugation, a concurrent increase
in CC and cTSI decrease was observed, suggestive
that this simple measure of peripheral fluid shifts may
have utility as a proxy of cerebral haemodynamics during
sustained SAHC.
Central hypovolaemia
Delta calf circumference, HR, TPR and mean arterial
pressure (MAP) all increased as a function of g-level,
as hypothesized based on previous findings (Goswami
et al. 2015a). Similarly, cTSI and SV decreased in
line with the literature (Smith et al. 2013). However,
we also observed an almost perfect linear relationship
between CC and HR, irrespective of position and
g-level. The strength of this relationship was unexpected
and suggests a consequential systemic response to calf
pooling, likely caused by volume shifts, and thus decreased
cardiac return (pre-load) and filling pressure (Rowell et al.
1996). Such a relationship is similar to that presented
by Hachiya et al. (2010) during lower body negative
pressure where differences in tolerant (rightward shift)
and intolerant (leftward shift) HR responses, as a function
of calf circumference, were explained by splanchnic region
constriction.
Whilst our study showed an increase in CC, the
effect upon splanchnic blood volume was not determined.
In fact, splanchnic vasoconstriction has been observed
in response to orthostatic challenge to maintain venous
return (Hinghofer-Szalkay et al. 2008; Blaber et al. 2013).
Thus, future studies should evaluate the relationship
between calf circumference and splanchnic blood volume
changes to SAHC.
Cerebral perfusion
It was hypothesized that cerebral perfusion support would
be observed at P3. However, this was not the case. One
possible explanation is that increased arterial headward
pressure results in venous congestion, thereby limiting
oxygenation. Further work is required to confirm this,
and to determine the relationship between jugular vein
congestion and cerebral haemodynamics with g-gradients.
Should venous congestion during in-body centrifugation
be confirmed, it may provide a valuable methodology
with which to investigate its role in spaceflight-acquired
neuro-ocular syndrome observed in some astronauts
(Zhang & Hargens, 2014).
Gravitational gradient
The ‘total gravitational exposure’, i.e. g-gradient across
the body (and thus pressure sensors), changes with each
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position despite a comparable +Gz level at the feet (Fig. 1).
It is known that the hydrostatic gradient is of critical
importance in determining an orthostatic challenge, and
the response to it, particularly during passive stress
(Hinghofer-Szalkay, 2011). Thus, resultant modification
of aortic and carotid baroreceptor feedback may explain
the fact that the cardiovascular response in P3 at a high
+Gz level was similar to that elicited at a low +Gz level
in P1. Furthermore, the g-gradient of P3 was shown
to increase g-tolerance – suggestive of preservation of
cerebral oxygenation – a key limiting factor for centrifuge
training.
Significant attenuations of g-induced changes in
cerebral perfusion, central hypovolaemia and systemic
cardiovascular response occurred at P3, the most striking
of which was HR. Interestingly, it has been post-
ulated that the hydrostatic gradient between the carotid
and aortic baroreceptors is a potent determinant of HR
responses to orthostatic challenge (Ferguson et al. 1985).
In the present study, at P3 the hydrostatic gradient was
reversed, suggesting (in isolation) that bradycardia should
ensue. However, HR at P3 represented a ‘dampened’
increase, likely due to the removal of central blood
volume having an opposing effect on HR. This working
hypothesis could be tested by prevention of the fluid shift
during centrifugation via the use of anti-g trousers (Gray
et al. 1969).
Varying g-gradients during AG: advantages over
current countermeasures
Current spaceflight countermeasures on board the Inter-
national Space Station attempt to ameliorate the effects of
gravitational unloading through an extensive daily exercise
programme (Petersen et al. 2016). Training consists of
treadmill running, cycle ergometry and resistive exercise,
which together have some (albeit variable) effectiveness
at reducing loss of muscle mass (Trappe et al. 2009),
bone density (Shackelford et al. 2004) and cardio-
respiratory function (Loehr et al. 2011). However, despite
such current countermeasures, typically 30–50% of all
returning astronauts demonstrate OI on return (Moore
et al. 1996; Blaber et al. 2011). It is postulated that
high OI incidence arises from the failure of current
countermeasures to counteract headward fluid shifts; thus
combining exercise with AG may prove more effective.
Limitations
An obvious criticism is the use of the cerebral tissue
saturation index as a proxy for cerebral blood delivery.
This approach has been validated, but it may have
been affected by changes in skin thickness (secondary)
due to fluid shifts and of course the reduction in flow
may have negatively affected NIRS signal quality (and
thus validity). Furthermore, this study did not measure
local pressure or volume changes during centrifugation;
pressure changes were calculated from referring g-profiles.
Speculation regarding pressure receptor stimulation
and arterial/venous HIP locations has been inferred
based upon studies of the cardiovascular responses
to postural changes (Hinghofer-Szalkay et al, 2011;
Patel et al. 2016). More research is needed to obtain
pressure/volume recordings during centrifugation in
order to differentiate the passive haemodynamic responses
from those generated by resultant autonomic regulation.
Conclusions
Our data confirm our hypothesis that movement of
RAP towards the heart (reduced g-gradient) independent
of foot-level Gz, reduced the orthostatic challenge
leading to improved g-tolerance. However, the role of
peripheral blood displacement remains unclear. Our
results suggest that RAP, and thus g-gradient, warrants
further investigation, specifically the effect of differential
baroreceptor feedback (i.e. aortic–carotid g-gradient)
as reduced cardiac filling may effect haemodynamic
regulation during and immediately following SAHC.
Our results demonstrate that SAHC g-gradient is
a critical factor in determining the haemodynamic
responses to centrifugation in addition to g-level
magnitude and duration. However, moving the axis of
rotation to the level of the heart probably decreases the
potential orthostatic training benefits of SAHC in micro-
gravity, although this, and its effect on the efficacy of
AG on other physiological systems, also warrants further
investigation.
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